Although natural PACAP is biologically unstable, pharmacological studies have led to the development of a metabolically stable PACAP38 analog, acetyl-[Ala15, Ala20]PACAP38-propylamide, which is a promising therapy for neurodegenerative diseases. This evidence concerns the gene ADCYAP1 and neurodegenerative disease.